GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JiangXi Tianxin Pharmaceutical Co Ltd (SHSE:603235) » Definitions » Net Income From Continuing Operations

JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Net Income From Continuing Operations : ¥515 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is JiangXi Tianxin Pharmaceutical Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. JiangXi Tianxin Pharmaceutical Co's net income from continuing operations for the three months ended in Mar. 2024 was ¥148 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ¥515 Mil.

JiangXi Tianxin Pharmaceutical Co Net Income From Continuing Operations Historical Data

The historical data trend for JiangXi Tianxin Pharmaceutical Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JiangXi Tianxin Pharmaceutical Co Net Income From Continuing Operations Chart

JiangXi Tianxin Pharmaceutical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
Get a 7-Day Free Trial 727.72 887.09 743.89 622.12 475.85

JiangXi Tianxin Pharmaceutical Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 108.60 221.36 82.95 62.95 147.55

JiangXi Tianxin Pharmaceutical Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥515 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JiangXi Tianxin Pharmaceutical Co Ltd (SHSE:603235) » Definitions » Net Income From Continuing Operations
Comparable Companies
SZSE:002946 SZSE:002626 SHSE:600305 SZSE:002216 SHSE:600186 SZSE:002840 SHSE:600597 SZSE:002100 SZSE:002567 SZSE:300973 XSWX:NESN KHC XPAR:BN GIS SHSE:603288 NSE:NESTLEIND SZSE:300999 SHSE:600887 TSE:2802 LSE:ABF
Traded in Other Exchanges
N/A
Address
Le'anjiang Industrial Park, Jiangxi Province, Leping, CHN, 333300
Website
http://www.txpharm.com
JiangXi Tianxin Pharmaceutical Co Ltd is engaged in the research and development, production and sales of monomeric vitamin products.

JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Headlines

No Headlines